Tanguler Tolga
Insider CIK 1849458 · ALNY EVP, Chief Commercial Officer · LXEO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 208 | $325.67 | $67.7K | 34,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 106 | $319.03 | $33.8K | 36,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 350 | $323.01 | $113.1K | 35,544 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 272 | $324.88 | $88.4K | 34,505 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 767 | $323.84 | $248.4K | 34,777 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 102 | $320.01 | $32.6K | 36,398 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 215 | $320.81 | $69.0K | 36,183 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 289 | $321.82 | $93.0K | 35,894 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-03-02 | 2026-03-04 | 10,480 | — | $0 | 10,480 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 47 | $323.62 | $15.2K | 38,157 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 170 | $329.71 | $56.1K | 36,818 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 81 | $330.85 | $26.8K | 36,737 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 94 | $331.93 | $31.2K | 36,643 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-03-02 | 2026-03-04 | 4,769 | — | $0 | 38,204 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 37 | $332.64 | $12.3K | 36,606 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 90 | $324.65 | $29.2K | 38,067 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 258 | $325.63 | $84.0K | 37,809 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 392 | $326.81 | $128.1K | 37,417 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 329 | $327.67 | $107.8K | 37,088 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 100 | $328.71 | $32.9K | 36,988 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2026-02-27 | 2026-03-02 | 1,666 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2026-02-27 | 2026-03-02 | 1,666 | — | $0 | 33,435 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-13 | 2026-02-17 | 1,959 | $310.08 | $607.4K | 31,769 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-02-12 | 2026-02-17 | 4,000 | — | $0 | 33,728 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 39 | $353.95 | $13.8K | 31,199 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 19 | $375.65 | $7.1K | 29,743 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 14 | $374.44 | $5.2K | 29,762 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 2 | $372.46 | $745 | 29,776 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 19 | $370.87 | $7.0K | 29,778 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 40 | $369.48 | $14.8K | 29,797 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 92 | $368.62 | $33.9K | 29,837 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 41 | $367.40 | $15.1K | 29,929 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 50 | $366.41 | $18.3K | 29,970 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 220 | $365.56 | $80.4K | 30,020 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 199 | $364.83 | $72.6K | 30,240 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 47 | $363.55 | $17.1K | 30,439 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 73 | $362.38 | $26.5K | 30,486 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 98 | $361.45 | $35.4K | 30,559 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 155 | $360.22 | $55.8K | 30,657 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 85 | $359.14 | $30.5K | 30,812 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 123 | $358.18 | $44.1K | 30,897 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 96 | $357.17 | $34.3K | 31,020 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 41 | $356.09 | $14.6K | 31,116 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 42 | $355.16 | $14.9K | 31,157 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 15 | $377.82 | $5.7K | 29,728 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-01-11 | 2026-01-14 | 3,800 | — | $0 | 31,238 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 1 | $457.64 | $458 | 27,438 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 55 | $446.53 | $24.6K | 28,788 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 27 | $447.92 | $12.1K | 28,761 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 35 | $455.82 | $16.0K | 27,509 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 70 | $457.43 | $32.0K | 27,439 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 86 | $448.77 | $38.6K | 28,675 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 119 | $449.79 | $53.5K | 28,556 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 260 | $450.81 | $117.2K | 28,296 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 159 | $451.86 | $71.8K | 28,137 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 319 | $452.69 | $144.4K | 27,818 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 157 | $453.77 | $71.2K | 27,661 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 117 | $454.84 | $53.2K | 27,544 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 2,851 | — | $0 | 28,843 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-29 | 2025-09-02 | 144 | $452.49 | $65.2K | 25,992 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-29 | 2025-09-02 | 266 | $451.52 | $120.1K | 26,136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-29 | 2025-09-02 | 195 | $445.53 | $86.9K | 29,271 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-29 | 2025-09-02 | 899 | $446.98 | $401.8K | 28,372 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-29 | 2025-09-02 | 1,289 | $448.05 | $577.5K | 27,083 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-29 | 2025-09-02 | 681 | $449.54 | $306.1K | 26,402 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 12 | $455.82 | $5.5K | 29,466 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 241 | $454.84 | $109.6K | 29,478 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 543 | $454.04 | $246.5K | 29,719 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 329 | $452.96 | $149.0K | 30,262 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 103 | $451.99 | $46.6K | 30,591 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 39 | $450.92 | $17.6K | 30,694 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 90 | $449.92 | $40.5K | 30,733 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 39 | $447.98 | $17.5K | 30,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-08-15 | 2025-08-19 | 2,851 | — | $0 | 30,862 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 14,583 | — | $0 | 14,583 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-03-03 | 2025-03-05 | 7,819 | — | $0 | 7,819 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 131 | $242.37 | $31.8K | 28,351 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 3 | $247.35 | $742 | 28,011 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-03-03 | 2025-03-05 | 14,137 | — | $0 | 28,482 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 142 | $243.36 | $34.6K | 28,209 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 29 | $246.18 | $7.1K | 28,014 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 70 | $245.26 | $17.2K | 28,043 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 96 | $244.41 | $23.5K | 28,113 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 28 | $236.51 | $6.6K | 14,830 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 22 | $238.33 | $5.2K | 14,808 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 23 | $239.18 | $5.5K | 14,785 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 38 | $244.11 | $9.3K | 14,345 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 78 | $243.23 | $19.0K | 14,383 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 192 | $242.44 | $46.5K | 14,461 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 82 | $241.51 | $19.8K | 14,653 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 50 | $240.32 | $12.0K | 14,735 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,667 | — | $0 | 1,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-02-27 | 2025-03-03 | 1,667 | — | $0 | 14,858 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 84 | $252.27 | $21.2K | 13,191 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 26 | $247.77 | $6.4K | 14,634 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 215 | $249.60 | $53.7K | 14,419 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 318 | $250.68 | $79.7K | 14,101 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 826 | $251.42 | $207.7K | 13,275 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-11-25 | 2024-11-27 | 3,000 | — | $0 | 14,660 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2024-11-11 | 2024-11-13 | 36,000 | — | $0 | 36,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 18 | $225.55 | $4.1K | 13,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 13 | $224.17 | $2.9K | 13,193 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 59 | $221.71 | $13.1K | 13,206 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 167 | $235.19 | $39.3K | 11,660 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 185 | $234.66 | $43.4K | 11,827 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 115 | $233.53 | $26.9K | 12,012 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 216 | $232.54 | $50.2K | 12,127 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 99 | $231.59 | $22.9K | 12,343 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 304 | $229.93 | $69.9K | 12,442 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 266 | $229.06 | $60.9K | 12,746 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 129 | $228.30 | $29.5K | 13,012 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 34 | $226.82 | $7.7K | 13,141 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-06-24 | 2024-06-26 | 3,278 | — | $0 | 13,265 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 9,279 | — | $0 | 9,279 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-03-01 | 2024-03-05 | 4,751 | — | $0 | 9,987 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 14 | $157.30 | $2.2K | 5,237 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 216 | $154.54 | $33.4K | 5,521 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 1 | $158.09 | $158 | 5,236 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 100 | $156.38 | $15.6K | 5,251 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 170 | $155.45 | $26.4K | 5,351 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-27 | 2024-02-29 | 1,667 | — | $0 | 3,333 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-27 | 2024-02-29 | 1,667 | — | $0 | 5,737 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 121 | $149.03 | $18.0K | 4,070 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 369 | $147.50 | $54.4K | 4,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 519 | $148.24 | $76.9K | 4,191 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-02-15 | 2024-02-20 | 3,278 | — | $0 | 5,079 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 122 | $193.18 | $23.6K | 3,155 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 625 | $194.94 | $121.8K | 1,968 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 562 | $193.93 | $109.0K | 2,593 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 64 | $195.65 | $12.5K | 1,904 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 103 | $197.08 | $20.3K | 1,801 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-04-26 | 2023-04-28 | 3,277 | — | $0 | 3,277 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 10,352 | — | $0 | 10,352 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-03 | 2023-02-03 | 865 | $231.35 | $200.1K | 2,246 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-03 | 2023-02-03 | 185 | $230.20 | $42.6K | 3,111 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-03 | 2023-02-03 | 128 | $227.68 | $29.1K | 3,296 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-03 | 2023-02-03 | 1,293 | $232.53 | $300.7K | 953 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-03 | 2023-02-03 | 953 | $233.31 | $222.3K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 561 | $226.62 | $127.1K | 3,428 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 963 | $225.80 | $217.4K | 3,989 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 73 | $223.97 | $16.3K | 4,952 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 4 | $227.38 | $910 | 3,424 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-01 | 2023-02-03 | 5,025 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-01 | 2023-02-03 | 5,025 | — | $0 | 5,025 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 104 | $225.15 | $23.4K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 5 | $224.00 | $1.1K | 104 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 105 | $220.95 | $23.2K | 109 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 99 | $219.53 | $21.7K | 214 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 541 | $218.71 | $118.3K | 313 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 440 | $217.61 | $95.7K | 854 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 398 | $216.21 | $86.1K | 1,294 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-05 | 2022-08-05 | 149 | $215.03 | $32.0K | 1,692 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 170 | $210.50 | $35.8K | 1,841 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 1,618 | $189.76 | $307.0K | 2,011 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-08-03 | 2022-08-05 | 1,754 | $210.00 | $368.3K | 3,629 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,629 | — | $0 | 5,383 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-07-05 | 2022-07-07 | 1,754 | $150.00 | $263.1K | 1,754 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 18,413 | — | $0 | 18,413 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-02-02 | 2022-02-03 | 1,518 | $144.67 | $219.6K | 3,508 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-02-01 | 2022-02-03 | 5,026 | — | $0 | 5,025 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-02-01 | 2022-02-03 | 5,026 | — | $0 | 5,026 | SEC↗ |